Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats.

[1]  B. Kemp,et al.  Platelet-Derived Growth Factor Receptor Transactivation Mediates the Trophic Effects of Angiotensin II In Vivo , 2004, Hypertension.

[2]  E. Lakatta,et al.  Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell Function , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  S. Kudoh,et al.  Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II , 2004, Nature Cell Biology.

[4]  A. Takeshita,et al.  Critical Role of Monocyte Chemoattractant Protein-1 Receptor CCR2 on Monocytes in Hypertension-Induced Vascular Inflammation and Remodeling , 2004, Circulation research.

[5]  Z. Ungvari,et al.  Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. , 2004, Physiological genomics.

[6]  H. Bergmeister,et al.  Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity. , 2004, Blood.

[7]  M. Runge,et al.  Age-related changes in matrix metalloproteinase-9 regulation in cultured mouse aortic smooth muscle cells , 2004, Experimental Gerontology.

[8]  E. Lakatta,et al.  Aging Increases Aortic MMP‐2 Activity and Angiotensin II in Nonhuman Primates , 2003, Hypertension.

[9]  Daniel Levy,et al.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. , 2003, Circulation.

[10]  Marta Ruiz-Ortega,et al.  Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. , 2002, Kidney international. Supplement.

[11]  J. Rutledge,et al.  Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. , 2002, Physiological genomics.

[12]  C. Ferrario,et al.  Mechanisms linking angiotensin II and atherogenesis , 2002, Current opinion in lipidology.

[13]  Hua Cai,et al.  Role of p47phox in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II , 2002, Hypertension.

[14]  R. Levi,et al.  Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release. , 2002, The Journal of pharmacology and experimental therapeutics.

[15]  P. Dempsey,et al.  Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. , 2002, Biochemical and biophysical research communications.

[16]  Z. Ungvari,et al.  Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function , 2002, Circulation research.

[17]  A. Parenti,et al.  Inhibition of Vascular Smooth Muscle Cell Growth by Angiotensin Type 2 Receptor Stimulation for In Vitro Organ Culture Model , 2002, Journal of cardiovascular pharmacology.

[18]  E. Lakatta,et al.  Altered Regulation of Matrix Metalloproteinase-2 in Aortic Remodeling During Aging , 2002, Hypertension.

[19]  E. Lakatta,et al.  Functional Correlates of Central Arterial Geometric Phenotypes , 2001, Hypertension.

[20]  B. Lévy,et al.  Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation , 2001, Hypertension.

[21]  B. Williams,et al.  Angiotensin II and the pathophysiology of cardiovascular remodeling. , 2001, The American journal of cardiology.

[22]  K. Amann,et al.  Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. , 2001, Biochemical and biophysical research communications.

[23]  T. Lüscher,et al.  Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.

[24]  Shokei Kim,et al.  In Vivo Activation of Rat Aortic Platelet-Derived Growth Factor and Epidermal Growth Factor Receptors by Angiotensin II and Hypertension , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[25]  M. Aoki,et al.  Ribozyme Oligonucleotides Against Transforming Growth Factor-&bgr; Inhibited Neointimal Formation After Vascular Injury in Rat Model: Potential Application of Ribozyme Strategy to Treat Cardiovascular Disease , 2000, Circulation.

[26]  D. Ganten,et al.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. , 2000, The American journal of pathology.

[27]  A. Orlandi,et al.  Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Bradford D. Winters,et al.  Subtype Specific Regulation of Human Vascular α1-Adrenergic Receptors by Vessel Bed and Age , 1999 .

[29]  G. Gabbiani,et al.  Augmented expression of inducible NO synthase in vascular smooth muscle cells during aging is associated with enhanced NF-kappaB activation. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[30]  D. Ku,et al.  Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. , 1999, American journal of physiology. Heart and circulatory physiology.

[31]  A. Tessitore,et al.  Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. , 1999, Circulation.

[32]  Z. Werb,et al.  Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.

[33]  M. Crow,et al.  Age-related changes in the signaling and function of vascular smooth muscle cells , 1999, Experimental Gerontology.

[34]  K. Arakawa,et al.  Differences in tissue angiotensin II-forming pathways by species and organs in vitro. , 1998, Hypertension.

[35]  Y. Niho,et al.  Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. , 1998, Hypertension.

[36]  X. H. Wu,et al.  Molecular mechanism(s) of action of norepinephrine on the expression of the angiotensinogen gene in opossum kidney cells. , 1998, Kidney international.

[37]  S. Nadaud,et al.  Circulating and cellular markers of endothelial dysfunction with aging in rats. , 1997, American journal of physiology. Heart and circulatory physiology.

[38]  M. Makuuchi,et al.  Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. , 1997, Circulation.

[39]  M. Kowala,et al.  Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo. , 1997, Journal of Clinical Investigation.

[40]  B. Lévy,et al.  Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. , 1996, The Journal of clinical investigation.

[41]  P. Libby,et al.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  C. Acar,et al.  Noninvasive detection of an increased vascular mass in untreated hypertensive patients. , 1994, American journal of hypertension.

[43]  E. Lakatta,et al.  Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. , 1994, Circulation research.

[44]  J. Michel,et al.  Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. , 1994, The American journal of physiology.

[45]  R. Head,et al.  Angiotensin II‐Mediated Facilitation of Sympathetic Neurotransmission in the Spontaneously Hypertensive Rat Is Not Associated with Neuronal Uptake of the Peptide , 1993, Journal of cardiovascular pharmacology.

[46]  M. Safar,et al.  Role of adrenergic tone in mechanical and functional properties of carotid artery during aging. , 1993, The American journal of physiology.

[47]  T. Inagami,et al.  Peptide growth factors markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.

[48]  R. Virmani,et al.  Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. , 1991, The American journal of pathology.

[49]  G. Arnaldi,et al.  Effects of Hypertension and Aging on Platelet‐Derived Growth Factor and Platelet‐Derived Growth Factor Receptor Expression in Rat Aorta and Heart , 1991, Hypertension.

[50]  A. Chobanian,et al.  Blood pressure lowering diminishes age-related changes in the rat aortic intima. , 1984, Hypertension.

[51]  A. Chobanian,et al.  Aortic Endothelial and Subendothelial Cells in Experimental Hypertension and Aging , 1981, Hypertension.

[52]  Khan,et al.  Effects of , 2000, The Journal of organic chemistry.

[53]  E. Lakatta,et al.  Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. , 1999, Hypertension.

[54]  E. Schiffrin,et al.  Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. , 1999, Hypertension.

[55]  B. Winters,et al.  Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. , 1999, Circulation.

[56]  M. Crow,et al.  Vascular smooth muscle cell cultures. , 1997, Methods in cell biology.

[57]  Inhibition of the Renin-Angiotensin System in the Rat , 2022 .

[58]  and Aging of , 2022 .